Strategic Trust Kelly CRISPR & Gene Editing Technology ETF

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch XDNA and buy or sell other stocks, ETFs, and their options commission-free!

About XDNA

XDNA tracks a market-cap-weighted index of companies in developed markets that focus on the advancements in DNA modification technology. 

XDNA Key Statistics

AUM
AUM
Price-Earnings ratio
Price-Earnings ratio
30-Day yield
30-Day yield
Average volume
5.09K
Average volume5.09K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$11.83
52 Week high$11.83
52 Week low
$5.87
52 Week low$5.87
Expense ratio
Expense ratio

Stock Snapshot

As of today, Strategic Trust Kelly CRISPR & Gene Editing Technology ETF(XDNA) shares are valued at $7.38. The company's market cap stands at 2.58M, with a dividend yield of 51.3%.

On 2026-02-03, Strategic Trust Kelly CRISPR & Gene Editing Technology ETF(XDNA) shares started trading at —, with intraday highs of — and lows of —.

Trading activity shows a volume of 0, compared to an average daily volume of 5.09K.

Over the past 52 weeks, Strategic Trust Kelly CRISPR & Gene Editing Technology ETF(XDNA) stock has traded between a high of $11.83 and a low of $5.87.

Over the past 52 weeks, Strategic Trust Kelly CRISPR & Gene Editing Technology ETF(XDNA) stock has traded between a high of $11.83 and a low of $5.87.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Performance data represents past performance and is no guarantee of future results. Investment returns and principal value will fluctuate and are subject to market volatility. An investment, when redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance data quoted. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.